Project like this . Mr. Ballmer yeah, its an effort we started about four ago with me trying to actually understand our better. Nt by the governments own numbers. How big is the government. Come does the tax base from, what what do things get spent on and what are the outcomes . Said lets use the discipline that a company would shareholders. To the securities and Exchange Commission requires a factual 10k reportled a and we started out on the journey and weve really learned lot by sorting through numbers not only at the federal level local the state and level. And what about the need for realnumbers, real data, facts, in the middle of the kind of situation that the country is the coronavirus epidemic . Mr. Ballmer its more essential ever and well suffer with some of the other problems we see with government data. Timenment data has a hard staying current, staying recent. You look at historical numbers on the Affordable Care act and medicaid. Theyre two, three years out of date. Right n
[inaudible conversations] good morning the subcommittee will now come to order. Welcome to everyone that is here in the hearing room. The chair now recognizes herself for an opening statement. According to dhs National Survey on drug use, 44 million americans reported using cannabis in the last year. Thirtythree states now allow the medicinal use of cannabis and in the district of columbia have legalized for adult use. State laws and federal policy are 1000 miles apart. The federal governments still strictly prohibits even restricting legitimate medical research. Widespread availability of cannabis is the purpose of the hearing to examine the pressing need for medical research of cannabis and the chemical compound with cbd being one of them. Half a century ago the congress listed cannabis as schedule one substance including heroin heroine, lsd, and ecstasy. Schedule one drugs have no medical value in high potential for abuse. Scheduled to drugs such as cocaine and vicodin even schedule
[inaudible conversations] good morning the subcommittee will now come to order. Welcome to everyone that is here in the hearing room. The chair now recognizes herself for an opening statement. According to dhs National Survey on drug use, 44 million americans reported using cannabis in the last year. Thirtythree states now allow the medicinal use of cannabis and in the district of columbia have legalized for adult use. State laws and federal policy are 1000 miles apart. The federal governments still strictly prohibits even restricting legitimate medical research. Widespread availability of cannabis is the purpose of the hearing to examine the pressing need for medical research of cannabis and the chemical compound with cbd being one of them. Half a century ago the congress listed cannabis as schedule one substance including heroin heroine, lsd, and ecstasy. Schedule one drugs have no medical value in high potential for abuse. Scheduled to drugs such as cocaine and vicodin even schedule
[captioning made possible by the national captioning institute, inc. , in cooperation with the United States house of representatives. Any use of the closedcaptioned coverage of the house proceedings for political or commercial purposes is expressly prohibited by the u. S. House of representatives. ] the chair on this vote, the yeas are 89 and the nays are 341, the amendment is not adopted. The the Unfinished Business is request for recorded vote on number 45 printed in part f house report 118216 and proceedings were postponed and the clerk will redesignate the amendment. The clerk amendment number 45 printed in house report 118216 offered by mr. Perry of pennsylvania. The chair a reported a recorded vote has been ordered. Members will record their votes by electronic device. This is a twominute vote. [captioning made possible by the national captioning institute, inc. , in cooperation with the United States house of representatives. Any use of the closedcaptioned coverage of the house
Does the f. D. A. Encounter adverse events with o. T. C. Medicines . Dr. Woodcock i would say fairly frequently. To rise to a serious level, maybe once every several years. Mr. Butterfield frequently or infrequently . Dr. Woodcock fairly frequently. Given what they are and the exposure of the population to them but once perhaps every two years were facing an issue that we would like to get out rapidly to the public to notify them and our hands are really tied and we have to use this guidance process. Mr. Butterfield all right. Two other examples you highlighted in your written testimony related to pediatric issues with certain medicines. Would you say that a dispr portionate number of safety concerns with o. T. C. Medicines are related to pediatrics . Dr. Woodcock i would say in the last decade that is true, a decade or so, and the reason is starting in the late 1990s i think everyone became aware that you should study children and not just treat them as tiny adults and just scale down